For the modern surgeon, the boundary between clinical practice and industry innovation has never been more productive, or more scrutinized. While collaborating with medical device companies is essential for advancing patient care, recent federal activity has signaled a "new normal" in how the Department of Justice (DOJ) views these relationships. As an "investor-physician" or "Doctorpreneur," understanding the shifting landscape of the Anti-Kickback Statute (AKS) is no longer just a task for...

"If the market experienced a 15% correction tomorrow, would your retirement date move back by five years, or are you holding assets that don’t care what Wall Street thinks?" In professional practice, uncertainty is a variable we manage with objective data. In the financial landscape of March 2026, uncertainty has become the baseline. We are navigating a precarious global environment: while public indices hit nominal highs, the escalation of geopolitical conflicts and international instability...

"As a clinician, you would never accept a 'passive' approach to a patient’s recovery—is it time to apply that same diagnostic rigor to your retirement infrastructure?"   For the mid-career physician, March represents a natural financial checkpoint. While the broader markets often focus on "spring cleaning" traditional portfolios, the sophisticated medical investor looks deeper at the foundations of their autonomy. In the current 2026 economic landscape, marked by shifting reimbursement...